1. Ahsan H., Chen Y., Whittemore A. S., Kibriya M. G., Gurvich I., Senie R. T. and Santella R. M. 2004 A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk. Breast Cancer Res. Treat.
85, 121–131.
2. Ambrosone C. B., Freudenheim J. L., Graham S., Marshall J. R., Vena J. E., Brasure J. R., et al. 1995 Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res.
55, 3483–3485.
3. Amrani I., Bulatova N., Awidi A., Yousef A. M., Melhem J. M., Al-Masri M. and Tahoun L. A. 2016 Lack of association between CYP1A1 M2 and M4 polymorphisms and breast carcinoma in Jordanian women: a case-control study. Asian Pac. J. Cancer Prev.
17, 387–393.
4. Bailey L. R., Roodi N., Verrier C. S., Yee C. J., Dupont W. D. and Parl F. F. 1998 Breast cancer and CYP1A1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of associations in Caucasians and African Americans. Cancer Res.
58, 65–70.
5. Basham V. M., Pharoah P. D., Healey C. S., Luben R. N., Day N. E., Easton D. F. et al. 2001 Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk. Carcinogenesis
22, 1797–1800.